Delivery Order SPE2DB20D3104-SPE2DB24FV9N7

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price delivery order is for the medication Emgality 120 mg/ml pen injector, and has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, valued at $1,002.72, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Emgality 120 mg/mL pen, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on an indefinite delivery contract (IDC) with DLA,...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,005.44 firm-fixed-price delivery order is for the drug Emgality 120 mg/ml pen, with an ultimate completion date of October 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,729.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Emgality 120 mg/ml pen, with a performance period ending on May 6, 2025. This award is not associated with a set-aside program and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Emgality 120 mg/ml pens. The contract has a ceiling value of $1,729 and was awarded by the Defense Logistics Agency (DLA), a defense agency, on February 3, 2025, with a final completion date of February 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.60 Firm Fixed Price delivery order is for the medication Emgality 120 mg/ml Pen ML, with a period of performance through November 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,625.74, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of the pharmaceutical product Emgality 120 mg/ml pen. This is a firm-fixed-price delivery order contract with a completion date of May 20, 2024. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,097.06 firm fixed-price delivery order is for the pharmaceutical product Emgality 120 mg/ml penml. The contract has a completion date of September 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to supply a wide range of medications and medical supplies...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at up to $1,741.50, is a firm fixed price delivery order for the pharmaceutical product Emgality 120 mg/ml penml. This award is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Emgality 120 mg/ml pen. The $1,850.07 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts like this one for specific medications. The...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV9N7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) was issued by the Defense Logistics Agency (DLA) for the delivery of Emgality 120 mg/ml Pen. The $1,002.72 firm-fixed-price delivery order has a period of performance through September 17, 2024 and is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this award, which is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that the company holds with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 11:37 AM